ArticleEuropean journal of medical research2025
Associations of growth differentiation factor 15 with kidney function in frail and pre-frail older individuals: the mediating role of inflammation and oxidative stress.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThis cross-sectional investigation aimed to investigate the association of plasma Growth Differentiation Factor 15 (GDF-15) with kidney function in frail and pre-frail older individuals, and to further test the mediating roles of inflammation and oxidative stress.
methods483 older adults (71.64 ± 6.07 years) with frailty or pre-frailty status were included. Plasma GDF-15 was measured using enzyme-linked immunosorbent assay. An estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73m
resultsBoth the absolute concentration and the ln-transformed concentration of GDF-15 were significantly negatively correlated with eGFR (both P < 0.001). In the multivariate logistic analysis, the odds ratio (OR) of kidney dysfunction for per 1-SD increase in GDF-15 was 1.36 (95% CI 1.04-1.78). Compared with the first quartile group of GDF-15, the OR of kidney dysfunction in the third quartile group was 2.74 (95% CI 1.44-5.23, P = 0.002). Tumor necrosis factor, malondialdehyde, and glutathione peroxidase mediated the relationship between GDF-15 and eGFR, with mediating proportions of 7.23%, 8.41%, and 9.83%, respectively.
conclusionsOur findings suggest that high levels of GDF-15 are associated with lower eGFR in frail and pre-frail older individuals. GDF-15 may be related to kidney function through its involvement in inflammatory and oxidative stress responses.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.